Results from a randomized, double-blind trial in diabetes-free adults living with obesity and high cardiovascular disease risk showed that liraglutide was associated with a reduction in both muscle ...

IRVINE, Calif.--(BUSINESS WIRE)--Immunis, Inc., a clinical-stage biotech developing novel secretomes for age-related diseases and immune dysfunction, has initiated non-terminal safety studies with ...